Loading clinical trials...
Loading clinical trials...
The objective of this study is to investigate the efficacy of olanzapine as compared to neurokinin-1 receptor antagonists (NK1-RAs) in the prevention of chemotherapy-induced nausea and vomiting (CINV)...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Michigan Rogel Cancer Center
NCT07296887 · Gynecologic Cancer, Prostate Cancer, and more
NCT05787561 · Mesonephric Gynecologic Cancer
NCT05559879 · Gynecologic Cancer, Carcinoma, and more
NCT05142033 · Cancer, Cancer Diagnosis, and more
NCT07447050 · Breast Cancer, Sarcoma, and more
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions